Newsletter | May 30, 2024

05.30.24 -- Injectable Medications: How To Stay Relevant & Patient Centric


Nitrosamines: New WHO Guidance Provides Expanded Risk Assessment Considerations

Nitrosamines are potential contaminants of drug products. Contamination can occur from synthesizing APIs and excipients, from leaching into the product from primary packaging, and more.


The Latest Trends In The Prevention And Treatment Of Cervical Cancer

Unearth what immune checkpoint inhibitors are showing promise in treating cervical cancer and how advancements in these treatments paired with additional strategies are improving patient outcomes.

Injectable Medications: Staying Relevant In Today's Patient-Centric Market

This e-book provides insight into some of the issues and trends shaping drug delivery and explores solutions promoting the efficiency, reliability, and safety of the pharmaceutical drug supply.


Glass Prefillable Syringe Solution Delivering Complex Biologics